Elizabeth Czerepak - May 15, 2025 Form 4 Insider Report for DELCATH SYSTEMS, INC. (DCTH)

Role
Director
Signature
/s/ Gerard Michel, Attorney-in-Fact
Stock symbol
DCTH
Transactions as of
May 15, 2025
Transactions value $
$0
Form type
4
Date filed
5/19/2025, 04:10 PM
Previous filing
May 28, 2024

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
CZEREPAK ELIZABETH Director C/O DELCATH SYSTEMS, INC.,, 566 QUEENSBURY AVENUE, QUEENSBURY /s/ Gerard Michel, Attorney-in-Fact 2025-05-19 0001263500

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DCTH Stock Option (right to buy) Award $0 +22.5K $0.00 22.5K May 15, 2025 Common Stock 22.5K $16.05 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option will vest and become exercisable at the rate of one-twelfth (1/12th) per month with the first such vesting to occur on May 15, 2025 and monthly thereafter for so long as the reporting person remains a director of the Issuer (and subject to the terms and conditions of the Issuer's 2020 Omnibus Equity Incentive Plan, as amended). The option will expire the earlier of 10 years from the grant date or, for vested options, two years from the last day of service.